Recently, Proya Cosmetics has officially joined hands with West China Hospital to drive collaborative innovation in mitochondrial anti-aging through an integrated Industry-University-Research-Medicine effort!
On July 22, Proya Cosmetics and West China Hospital officially signed a partnership agreement in Chengdu, Sichuan. The two parties will focus on cutting-edge research in the field of "mitochondrial anti-aging", explore the cellular mechanisms that connect mitochondrial function with skin aging, accurately identify key pathways and targets, accelerate the research, development and screening of high-efficiency anti-aging active ingredients, and lay a solid foundation for the subsequent application of research results. Yameng Hou, General Manager of Proya Cosmetics, Luo Fengming, President of West China Hospital, along with heads of relevant departments and clinical divisions, attended the signing ceremony to witness this important milestone together.
This collaboration marks another leap forward for Proya Cosmetics in both scientific depth and transformation efficiency within the field of mitochondrial anti-aging. As Yameng Hou, General Manager of Proya Cosmetics, stated: “By leveraging the profound accumulation of West China Hospital in this field, Proya Cosmetics will establish a solid core technological foundation for its mitochondrial-targeted product matrix, thereby providing consumers with more scientific and precise anti-aging solutions.”
Looking ahead, Proya Cosmetics will continue to expand the breadth and depth of our collaboration with West China Hospital. By carrying out core initiatives such as fundamental dermatological research on Chinese populations, co-developing and validating efficacy-driven products, and accelerating industrial translation, Proya Cosmetics will continue to strengthen the Industry–University–Research–Medicine ecosystem, driving the Chinese cosmetics industry toward a more scientific and high-quality stage of development.
Language
